Saliva as a diagnostic tool for periodontal disease: Current state and future directions

Periodontology 2000

Volumn 50, Issue 1, 2009, Pages 52-64

  Giannobile, William V ^a   Beikler, Thomas ^a   Kinney, Janet S ^a   Ramseier, Christoph A ^a   Morelli, Thiago ^a   Wong, David T ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; DIAGNOSTIC AGENT; PROTEOME; SALIVA PROTEIN;

ARTICLE; GENE EXPRESSION PROFILING; GENETICS; HUMAN; METABOLISM; METHODOLOGY; PERIODONTAL DISEASE; PERIODONTICS; SALIVA; TOOTH IMPLANTATION;

BIOLOGICAL MARKERS; DENTAL IMPLANTS; GENE EXPRESSION PROFILING; HUMANS; PERIODONTAL DISEASES; PERIODONTICS; PROTEOME; SALIVA; SALIVARY PROTEINS AND PEPTIDES;

EID: 64549092461     PISSN: 09066713     EISSN: 16000757     Source Type: Journal    
DOI: 10.1111/j.1600-0757.2008.00288.x     Document Type: Article

References (81)

1. Airila-Mansson S, Soder B, Kari K, Meurman JH. Influence of combinations of bacteria on the levels of prostaglandin E2, interleukin-1beta, and granulocyte elastase in gingival crevicular fluid and on the severity of periodontal disease. J Periodontol 2006 : 77 : 1025 1031.
2. Albandar JM, Brunelle JA, Kingman A. Destructive periodontal disease in adults 30 years of age and older in the United States, 1988-1994. J Periodontol 1999 : 70 : 13 29.
3. Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol 1999 : 4 : 1 6.
4. Armitage GC. The complete periodontal examination. Periodontol 2000 2004 : 34 : 22 33.
5. Azuma M. Fundamental mechanisms of host immune responses to infection. J Periodontal Res 2006 : 41 : 361 373.
6. Ballantyne J. Validity of messenger RNA expression analyses of human saliva. Clin Cancer Res 2007 : 13 : 1350 author reply 1351.
7. Beikler T, Flemmig TF. Implants in the medically compromised patient. Crit Rev Oral Biol Med 2003 : 14 : 305 316.
8. Beikler T, Flemmig TF. Implant versus tooth retention from the periodontal perspective. Perio 2006 : 3 : 167 176.
9. Berglundh T, Donati M. Aspects of adaptive host response in periodontitis. J Clin Periodontol 2005 : 32 (Suppl. 6 87 107.
10. Berglundh T, Persson L, Klinge B. A systematic review of the incidence of biological and technical complications in implant dentistry reported in prospective longitudinal studies of at least 5 years. J Clin Periodontol 2002 : 29 (Suppl. 3 197 212.
11. Birkedal-Hansen H. Role of matrix metalloproteinases in human periodontal diseases. J Periodontol 1993 : 64 (5 Suppl. 474 484.
12. Bonassi S, Neri M, Puntoni R. Validation of biomarkers as early predictors of disease. Mutat Res 2001 : 481 : 349 358.
13. Burt B. Position paper: epidemiology of periodontal diseases. J Periodontol 2005 : 76 : 1406 1419.
14. Christodoulides N, Mohanty S, Miller CS, Langub MC, Floriano PN, Dharshan P, Ali MF, Bernard B, Romanovicz D, Anslyn E, Fox PC, McDevitt JT. Application of microchip assay system for the measurement of C-reactive protein in human saliva. Lab Chip 2005 : 5 : 261 269.
15. D'Aiuto F, Ready D, Tonetti MS. Periodontal disease and C-reactive protein-associated cardiovascular risk. J Periodontal Res 2004 : 39 : 236 241.
16. Denny P, Hagen FK, Hardt M, Liao L, Yan W, Arellanno M, Bassilian S, Bedi GS, Boontheung P, Cociorva D, Delahunty CM, Denny T, Dunsmore J, Faull KF, Gilligan J, Gonzalez-Begne M, Halgand F, Hall SC, Han X, Henson B, Hewel J, Hu S, Jeffrey S, Jiang J, Loo JA, Ogorzalek Loo RR, Malamud D, Melvin JE, Miroshnychenko O, Navazesh M, Niles R, Park SK, Prakobphol A, Ramachandran P, Richert M, Robinson S, Sondej M, Souda P, Sullivan MA, Takashima J, Than S, Wang J, Whitelegge JP, Witkowska HE, Wolinsky L, Xie Y, Xu T, Yu W, Ytterberg J, Wong DT, Yates JR III., Fisher SJ. The proteomes of human parotid and submandibular/sublingual gland salivas collected as the ductal secretions. J Proteome Res 2008 : 7 : 1994 2006.
17. Ferreira SD, Silva GL, Cortelli JR, Costa JE, Costa FO. Prevalence and risk variables for peri-implant disease in Brazilian subjects. J Clin Periodontol 2006 : 33 : 929 935.
18. Fransson C, Lekholm U, Jemt T, Berglundh T. Prevalence of subjects with progressive bone loss at implants. Clin Oral Implants Res 2005 : 16 : 440 446.
19. Gemmell E, Yamazaki K, Seymour GJ. The role of T cells in periodontal disease: homeostasis and autoimmunity. Periodontol 2000 2007 : 43 : 14 40.
20. Giannobile WV. C-telopeptide pyridinoline cross-links. Sensitive indicators of periodontal tissue destruction. Ann N Y Acad Sci 1999 : 878 : 404 412.
21. Giannobile WV. Periodontal surveillance - implications in the promotion of public health. J Periodontol 2007 : 78 : 1177.
22. Goodson JM. Diagnosis of periodontitis by physical measurement: interpretation from episodic disease hypothesis. J Periodontol 1992 : 63 (4 Suppl. 373 382.
23. Grbic JT, Lamster IB, Celenti RS, Fine JB. Risk indicators for future clinical attachment loss in adult periodontitis. Patient variables. J Periodontol 1991 : 62 : 322 329.
24. Groenink J, Ligtenberg AJ, Veerman EC, Bolscher JG, Nieuw Amerongen AV. Interaction of the salivary low-molecular-weight mucin (MG2) with Actinobacillus actinomycetemcomitans. Antonie Van Leeuwenhoek 1996 : 70 : 79 87.
25. Groenink J, Walgreen-Weterings E, Nazmi K, Bolscher JG, Veerman EC, van Winkelhoff AJ, Nieuw Amerongen AV. Salivary lactoferrin and low-Mr mucin MG2 in Actinobacillus actinomycetemcomitans-associated periodontitis. J Clin Periodontol 1999 : 26 : 269 275.
26. Gusman H, Travis J, Helmerhorst EJ, Potempa J, Troxler RF, Oppenheim FG. Salivary histatin 5 is an inhibitor of both host and bacterial enzymes implicated in periodontal disease. Infect Immun 2001 : 69 : 1402 1408.
27. Guven Y, Satman I, Dinccag N, Alptekin S. Salivary peroxidase activity in whole saliva of patients with insulin-dependent (type-1) diabetes mellitus. J Clin Periodontol 1996 : 23 : 879 881.
28. Helmerhorst EJ, Oppenheim FG. Saliva: a dynamic proteome. J Dent Res 2007 : 86 : 680 693.
29. Hernandez M, Valenzuela MA, Lopez-Otin C, Alvarez J, Lopez JM, Vernal R, Gamonal J. Matrix metalloproteinase-13 is highly expressed in destructive periodontal disease activity. J Periodontol 2006 : 77 : 863 870.
30. Herr AE, Hatch AV, Throckmorton DJ, Tran HM, Brennan JS, Giannobile WV, Singh AK. Microfluidic immunoassays as rapid saliva-based clinical diagnostics. Proc Natl Acad Sci U S A 2007 : 104 : 5268 5273.
31. Higashi MK, Veenstra DL, del Aguila M, Hujoel P. The cost-effectiveness of interleukin-1 genetic testing for periodontal disease. J Periodontol 2002 : 73 : 1474 1484.
32. Houri-Haddad Y, Wilensky A, Shapira L. T-cell phenotype as a risk factor for periodontal disease. Periodontol 2000 2007 : 45 : 67 75.
33. Hu S, Xie Y, Ramachandran P, Ogorzalek Loo RR, Li Y, Loo JA, Wong DT. Large-scale identification of proteins in human salivary proteome by liquid chromatography/mass spectrometry and two-dimensional gel electrophoresis-mass spectrometry. Proteomics 2005 : 5 : 1714 1728.
34. Hu S, Wang J, Meijer J, Ieong S, Xie Y, Yu T, Zhou H, Henry S, Vissink A, Pijpe J, Kallenberg C, Elashoff D, Loo JA, Wong DT. Salivary proteomic and genomic biomarkers for primary Sjogren's syndrome. Arthritis Rheum 2007 : 56 : 3588 3600.
35. Hu S, Yu T, Xie Y, Yang Y, Li Y, Zhou X, Tsung S, Loo RR, Loo JR, Wong DT. Discovery of oral fluid biomarkers for human oral cancer by mass spectrometry. Cancer Genomics Proteomics 2007 : 4 : 55 64.
36. Hu S, Arellano M, Boontheung P, Wang J, Zhou H, Jiang J, Elashoff D, Wei R, Loo JA, Wong DT. Salivary proteomics for oral cancer biomarker discovery. Clin Cancer Res 2008 : 14 : 6246 6252.
37. Hu Z, Zimmermann BG, Zhou H, Wang J, Henson BS, Yu W, Elashoff D, Krupp G, Wong DT. Exon-level expression profiling: a comprehensive transcriptome analysis for oral fluids. Clin Chem 2008 : 54 : 824 832.
38. Jalil RA, Ashley FP, Wilson RF. The relationship between 48-h dental plaque accumulation in young human adults and the concentrations of hypothiocyanite, 'free' and 'total' lysozyme, lactoferrin and secretory immunoglobulin A in saliva. Arch Oral Biol 1992 : 37 : 23 28.
39. Kinney JS, Ramseier CA, Giannobile WV. Oral fluid-based biomarkers of alveolar bone loss in periodontitis. Ann N Y Acad Sci 2007 : 1098 : 230 251.
40. Kivela-Rajamaki M, Maisi P, Srinivas R, Tervahartiala T, Teronen O, Husa V, Salo T, Sorsa T. Levels and molecular forms of MMP-7 (matrilysin-1) and MMP-8 (collagenase-2) in diseased human peri-implant sulcular fluid. J Periodontal Res 2003 : 38 : 583 590.
41. Kwok V, Caton JG. Commentary: prognosis revisited: a system for assigning periodontal prognosis. J Periodontol 2007 : 78 : 2063 2071.
42. Li Y, Zhou X, St John MA, Wong DT. RNA profiling of cell-free saliva using microarray technology. J Dent Res 2004 : 83 : 199 203.
43. Li Y, Elashoff D, Oh M, Sinha U, St John MA, Zhou X, Abemayor E, Wong DT. Serum circulating human mRNA profiling and its utility for oral cancer detection. J Clin Oncol 2006 : 24 : 1754 1760.
44. Li Y, St John MA, Zhou X, Kim Y, Sinha U, Jordan RC, Eisele D, Abemayor E, Elashoff D, Park NH, Wong DT. Salivary transcriptome diagnostics for oral cancer detection. Clin Cancer Res 2004 : 10 : 8442 8450.
45. Listgarten MA. Structure of surface coatings on teeth. A review. J Periodontol 1976 : 47 : 139 147.
46. Lo YM, Tsui NB, Chiu RW, Lau TK, Leung TN, Heung MM, Gerovassili A, Jin Y, Nicolaides KH, Cantor CR, Ding C. Plasma placental RNA allelic ratio permits noninvasive prenatal chromosomal aneuploidy detection. Nat Med 2007 : 13 : 218 223.
47. Loos BG, Tjoa S. Host-derived diagnostic markers for periodontitis: do they exist in gingival crevice fluid? Periodontol 2000 2005 : 39 : 53 72.
48. Ma J, Kitti U, Teronen O, Sorsa T, Husa V, Laine P, Ronka H, Salo T, Lindqvist C, Konttinen YT. Collagenases in different categories of peri-implant vertical bone loss. J Dent Res 2000 : 79 : 1870 1873.
49. Malamud D. Salivary diagnostics: the future is now. J Am Dent Assoc 2006 : 137 : 284 286.
50. Mandel ID. The diagnostic uses of saliva. J Oral Pathol Med 1990 : 19 : 119 125.
51. Mandel ID. Markers of periodontal disease susceptibility and activity derived from saliva. In : Johnson NW, editor. Periodontal diseases - markers of disease susceptibility and activity. Cambridge, New York : Cambridge University Press, 1991 : 228 253.
52. Maron JL, Bianchi DW. Prenatal diagnosis using cell-free nucleic acids in maternal body fluids: a decade of progress. Am J Med Genet C Semin Med Genet 2007 : 145 : 5 17.
53. Millenium Research Group. Global markets for dental implants 2007. Millenium Research Group : Toronto, Canada, 2008.
54. Miller CS, King CP Jr., Langub MC, Kryscio RJ, Thomas MV. Salivary biomarkers of existing periodontal disease: a cross-sectional study. J Am Dent Assoc 2006 : 137 : 322 329.
55. Nakashima K, Giannopoulou C, Andersen E, Roehrich N, Brochut P, Dubrez B, Cimasoni G. A longitudinal study of various crevicular fluid components as markers of periodontal disease activity. J Clin Periodontol 1996 : 23 : 832 838.
56. Ng EK, Tsui NB, Lau TK, Leung TN, Chiu RW, Panesar NS, Lit LC, Chan KW, Lo YM. mRNA of placental origin is readily detectable in maternal plasma. Proc Natl Acad Sci USA 2003 : 100 : 4748 4753.
57. Nussbaumer C, Gharehbaghi-Schnell E, Korschineck I. Messenger RNA profiling: a novel method for body fluid identification by Real-Time PCR. Forensic Sci Int 2006 : 157 : 181 186.
58. Offenbacher S. Periodontal diseases: pathogenesis. Ann Periodontol 1996 : 1 : 821 878.
59. Oringer RJ, Palys MD, Iranmanesh A, Fiorellini JP, Haffajee AD, Socransky SS, Giannobile WV. C-telopeptide pyridinoline cross-links (ICTP) and periodontal pathogens associated with endosseous oral implants. Clin Oral Implants Res 1998 : 9 : 365 373.
60. Page RC, Kornman KS. The pathogenesis of human periodontitis: an introduction. Periodontol 2000 1997 : 14 : 9 11.
61. Park NJ, Li Y, Yu T, Brinkman BM, Wong DT. Characterization of RNA in saliva. Clin Chem 2006 : 52 : 988 994.
62. Ramseier CA, Morelli T, Kinney JS, Dubois M, Rayburn L, Giannobile WB. Periodontal disease. In : Wong DT, editor. Salivary diagnostics. Ames, Iowa, USA : Wiley-Blackwell, 2008.
63. Reiff RL. Serum and salivary IgG and IgA response to initial preparation therapy. J Periodontol 1984 : 55 : 299 305.
64. Roos-Jansaker AM. Long time follow up of implant therapy and treatment of peri-implantitis. Swed Dent J Suppl 2007 : 188 : 7 66.
65. Roos-Jansaker AM, Renvert S, Egelberg J. Treatment of peri-implant infections: a literature review. J Clin Periodontol 2003 : 30 : 467 485.
66. Roos-Jansaker AM, Lindahl C, Renvert H, Renvert S. Nine- to fourteen-year follow-up of implant treatment. Part II: presence of peri-implant lesions. J Clin Periodontol 2006 : 33 : 290 295.
67. Scannapieco FA, Ng P, Hovey K, Hausmann E, Hutson A, Wactawski-Wende J. Salivary biomarkers associated with alveolar bone loss. Ann N Y Acad Sci 2007 : 1098 : 496 497.
68. Seemann R, Hagewald SJ, Sztankay V, Drews J, Bizhang M, Kage A. Levels of parotid and submandibular/sublingual salivary immunoglobulin A in response to experimental gingivitis in humans. Clin Oral Investig 2004 : 8 : 233 237.
69. Seugnet L, Boero J, Gottschalk L, Duntley SP, Shaw PJ. Identification of a biomarker for sleep drive in flies and humans. Proc Natl Acad Sci USA 2006 : 103 : 19913 19918.
70. Sharma CG, Pradeep AR. Gingival crevicular fluid osteopontin levels in periodontal health and disease. J Periodontol 2006 : 77 : 1674 1680.
71. Snyderman R, Williams RS. Prospective medicine: the next health care transformation. Acad Med 2003 : 78 : 1079 1084.
72. Snyderman R, Langheier J. Prospective health care: the second transformation of medicine. Genome Biol 2006 : 7 : 104.
73. Snyderman R, Yoediono Z. Prospective care: a personalized, preventative approach to medicine. Pharmacogenomics 2006 : 7 : 5 9.
74. Taba M Jr., Kinney J, Kim AS, Giannobile WV. Diagnostic biomarkers for oral and periodontal diseases. Dent Clin North Am 2005 : 49 : 551 571.
75. Tabak LA. Point-of-care diagnostics enter the mouth. Ann N Y Acad Sci 2007 : 1098 : 7 14.
76. Talonpoika JT, Hamalainen MM. Type I collagen carboxyterminal telopeptide in human gingival crevicular fluid in different clinical conditions and after periodontal treatment. J Clin Periodontol 1994 : 21 : 320 326.
77. Taubman MA, Valverde P, Han X, Kawai T. Immune response: the key to bone resorption in periodontal disease. J Periodontol 2005 : 76 (11 Suppl. 2033 2041.
78. Teng YT, Sodek J, McCulloch CA. Gingival crevicular fluid gelatinase and its relationship to periodontal disease in human subjects. J Periodontal Res 1992 : 27 : 544 552.
79. Tonetti MS, D'Aiuto F, Nibali L, Donald A, Storry C, Parkar M, Suvan J, Hingorani AD, Vallance P, Deanfield J. Treatment of periodontitis and endothelial function. N Engl J Med 2007 : 356 : 911 920.
80. Yager P, Edwards T, Fu E, Helton K, Nelson K, Tam MR, Weigl BH. Microfluidic diagnostic technologies for global public health. Nature 2006 : 442 : 412 418.
81. Zubakov D, Hanekamp E, Kokshoorn M, van Ijcken W, Kayser M. Stable RNA markers for identification of blood and saliva stains revealed from whole genome expression analysis of time-wise degraded samples. Int J Legal Med 2008 : 122 : 135 142.